Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
No Data
Wedbush Cuts Price Target on Maze Therapeutics to $48 From $58, Keeps Outperform Rating
Maze Therapeutics Prices $150 Million Securities Offering
Maze Therapeutics Intends to Use Any Net Proceeds From Offering to Advance R&D of Its Product Candidates >MAZE
Maze Therapeutics Also Intends to Use Any Net Proceeds for General Corporate Purposes >MAZE
Express News | Maze Therapeutics Announces $150 Million Registered Offering
Press Release: Maze Therapeutics Announces $150 Million Registered Offering